Astellas Drops Suit Over Medicare Drug Price Negotiation Law

By Theresa Schliep (September 7, 2023, 9:13 PM EDT) -- Astellas Pharma on Wednesday dropped its challenge to the new Medicare drug price negotiation program after none of its products were selected for negotiation by the U.S. Department of Health and Human Services, taking a bit of heat off the agency as it faces a barrage of legal challenges to the landmark program....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!